{
  "ptid_time": "137_S_4299_2017-10-27",
  "img_path": "/data/qiuhui/data/adni/images/137_S_4299/2017-10-27/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 79,321 mm³, 114.6% above the reference mean. With a Z-score of 3.09 (99.9th percentile), this represents profound enlargement; whole brain volume measures 889,219 mm³, 4.2% below the reference mean. With a Z-score of -0.50 (30.7th percentile), this represents normal volume . ",
  "text_data": "Age is 82.8 years. Gender is Female. Education: 12 years. MMSE: 26.0. MoCA: 20.0. Logical Memory: 10.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 0.88 SUVR (moderate reduced). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The patient shows significant ventricular enlargement (Z-score 3.09), which is strongly associated with neurodegeneration, while whole brain volume is within normal limits. The MMSE (26) is borderline normal, but the MoCA (20) suggests cognitive impairment, consistent with possible MCI or early dementia. The absence of APOE4 and moderate amyloid burden (AV45) does not rule out neurodegenerative disease, as ventricular enlargement and cognitive scores are concerning.  \n\n**Diagnosis:** **MCI** (likely progressing toward dementia given ventricular enlargement and cognitive scores)  \n**Confidence:** **Medium** (clinical and imaging findings align with MCI, but lack of APOE4 and only moderate amyloid load introduce some uncertainty).",
  "timestamp": "2025-07-26T16:29:49.461908"
}